BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

InfraReDx enrolls first patient in CANARY trial

July 15, 2011
By Omar Ford
InfraReDx (Burlington, Massachusetts) is testing out a hypothesis in its CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow) trial that could prove beneficial in reducing the rate of peri-procedural heart attacks in patients identified as having high-risk lipid core plaques. (Medical Device Daily)
Read More

St. Jude Medical receives FDA approval for Epiducer

July 14, 2011
By Omar Ford

ChromaGen's lenses help aid color blind patients

July 13, 2011
By Omar Ford

NLST results create huge opportunity for med-tech

July 12, 2011
By Omar Ford
Late last month, the American College of Radiology Imaging Network (ACRIN; Philadelphia) along with the National Cancer Institute’s Lung Screening Study Group released the results of the National Lung Screening Trial (NLST). The study supports the idea that CT Screening in older, heavy smokers can reduce mortality rates by 20% compared to standard chest X-rays.  Nearly 53,000 current and heavy smokers between the ages of 55 and 74 at 33 sites across the U.S. were enrolled in NLST. (See full study here) It should be pointed out however that the study results show that CT Screening in these patients turned up a high...
Read More

St. Jude 'broadens' clinical study with FDA approved expansion

July 12, 2011
By Omar Ford
In the U.S. nearly 21 million adults are plagued with some type of depressive disorder, according to the National Institute of Mental Health. Of this number about four million live with severe depression that doesn't respond to medications,psychotherapy and electroconvulsive therapy. (Medical Device Daily)
Read More

ACR takes issue with imaging cut proposal

July 11, 2011
By Omar Ford

LuCED may reduce false-positives in cancer screening

July 8, 2011
By Omar Ford

J&J exits DES market

July 7, 2011
By Omar Ford
A few weeks ago, I made the mistake of going into the gym around 6 p.m. That's the time when all the body builders and athletes tend to circulate in the area. I also made the mistake of getting on the treadmill next to someone who obviously looks like he runs track for a living. After seeing him run close to 10 mph without breaking a sweat - and I was struggling to do six -  I left the gym dejected. The competition in there was just too great. How could I possibly keep up with someone who can do a mile...
Read More

NLST results show 20% reduction in lung cancer deaths for CT scan

July 7, 2011
By Omar Ford

ImageIQ's partnership with NASA could boost profile

July 6, 2011
By Omar Ford
A newly launched Cleveland Clinic spin-off is grabbing some attention due to a partnership with National Aeronautics and Space Administration's (NASA) Ames Research Center, and the Midura Laboratory at the Lerner Research Institute (Cleveland). (Medical Device Daily)
Read More
Previous 1 2 … 150 151 152 153 154 155 156 157 158 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing